Caplin Point Laboratories share news and announcements

NSE: CAPLIPOINTBSE: 524742Pharmaceuticals & BiotechnologySmall Cap

₹2,222.00₹27.10 (1.20%)BSE ₹2,222.15

Share price at the NSE close on 23 Oct 2026. Previous close ₹2,249.10.

52-week range of traded prices to 23 Oct 2026

₹1,500.30Low, 30 Mar 2026₹2,990.00High, 24 Sep 2026

Market cap: ₹16,890 Cr453rd largest listed
P/E: 25.4
P/B: 4.7
Dividend yield: 0.36%
ROE: 20.7%
ROCE: 19.8%
Debt to equity: 0.00
Volume, NSE: 76,90447.0% delivered

Caplin Point Laboratories shareholding disclosures

30 filed, newest first.

Jun 2026
- 16 Jun · Disclosure
  Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. (opens in a new tab)
Sep 2025
- 29 Sep · Disclosure
  Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. (opens in a new tab)
Apr 2024
- 4 Apr · Disclosure
  Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. (opens in a new tab)
Jun 2023
- 13 Jun · Disclosure
  Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. (opens in a new tab)
Apr 2023
- 11 Apr · Disclosure
  Allotment of 19000 Shares. (opens in a new tab)
Apr 2022
- 1 Apr · Disclosure
  Promoter/Promoter Group of Caplin Point Laboratories Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022 (opens in a new tab)
Feb 2022
- 3 Feb · Disclosure
  Allotment of 20000 Shares. (opens in a new tab)
Nov 2021
- 3 Nov · Disclosure
  Allotment of 126126 Shares. (opens in a new tab)
Apr 2021
- 20 Apr · Disclosure
  Disclosure under Regulation 30 of SEBI SAST Regulations, 2011 as at March 31, 2021. (opens in a new tab)
May 2020
- 13 May · Disclosure
  Disclosure under Regulation 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation, 2011 (opens in a new tab)
May 2019
- 31 May · Disclosure
  Allotment of 12500 Equity Shares under ESOP (opens in a new tab)
Apr 2019
- 2 Apr · Disclosure
  Annual Disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers), Regulations, 2011 as on March 31, 2019. (opens in a new tab)
Feb 2019
- 13 Feb · Disclosure
  Allotment of 26750 Equity Shares under ESOP (opens in a new tab)
Apr 2018
- 5 Apr · Disclosure
  Disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
Feb 2018
- 15 Feb · Disclosure
  Allotment of 26750 Equity Shares under ESOP (opens in a new tab)
- 7 Feb · Disclosure
  Grant of 84000 Options. (opens in a new tab)
Apr 2017
- 10 Apr · Disclosure
  Copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 6 Apr · Disclosure
  Vide letter dated April 03, 2017 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 5 Apr · Disclosure
  Nomination and Remuneration Committee of the Board of Directors of the Company has granted 2,88,500 stock options to twenty four employees of the Company under Caplin Point Employee Stock Option Plan -2015 at an exercise price of Rs.2/- each. The employees are eligible to exercise /subscribe for equivalent number of equity shares of the Company having face value of Rs.2/- each. All these options will vest in three to four equal tranches over a period of three to four years (opens in a new tab)
Feb 2017
- 10 Feb · Disclosure
  Allotment of 26750 Equity Shares under ESOP (opens in a new tab)
Apr 2016
- 8 Apr · Disclosure
  Vide letter dated April 01, 2016 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
Feb 2016
- 10 Feb · Disclosure
  Nomination and Remuneration Committee of the Board of Directors of the Company has granted 16,050 stock options under the Caplin Point Employee Stock Option Plan -2015 at an exercise price of Rs.10 each, Convertible into equivalent number of Equity shares of the Company having face value of Rs.10 each. These options will vest in 3 equal tranches over a period of 3 years. (opens in a new tab)
Jun 2015
- 19 Jun · Disclosure
  Vide letter dated June 18, 2015 a copy of disclosures under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
Apr 2015
- 13 Apr · Disclosure
  Vide letter dated April 03, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
Mar 2015
- 4 Mar · Disclosure
  Vide letter dated March 4, 2015 a copy of disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 4 Mar · Disclosure
  Vide letter dated March 4, 2015 a copy of disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 3 Mar · Disclosure
  Vide letter dated March 3, 2015 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 3 Mar · Disclosure
  Vide letter dated March 3, 2015 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
Feb 2015
- 24 Feb · Disclosure
  Vide letter dated February 23, 2015 a copy of disclosure under Regulation 10(5) - Intimation to Stock Exchanges in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. (opens in a new tab)
- 24 Feb · Disclosure
  Vide letter dated February 23, 2015 a copy of disclosures under Regulation 10(5) - Intimation to Stock Exchanges in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. (opens in a new tab)

Caplin Point Laboratories shareholding disclosures

Jun 2026

Sep 2025

Apr 2024

Jun 2023

Apr 2023

Apr 2022

Feb 2022

Nov 2021

Apr 2021

May 2020

May 2019

Apr 2019

Feb 2019

Apr 2018

Feb 2018

Apr 2017

Feb 2017

Apr 2016

Feb 2016

Jun 2015

Apr 2015

Mar 2015

Feb 2015